SEARCH CONTACT US

ACCESSIBILITY

24/7

Headlines

25-year-old AI investor’s $16 billion bet hits a brutal reality check

Israel’s cyber industry bets identity will become the next AI security battleground

Israeli startups raised $1.5 billion in July as investors doubled down on enterprise AI

Why Israel may need to take its most secret missile maker public

Buzz

Most popular

Daily

Weekly

1

Israel searches for technology that could find soldiers and pilots who cannot call for help

2

Another 10 U.S. tankers are headed to Israel's Ben Gurion as airport delays mount

3

After IAI and Rafael, secretive missile engine maker Tomer moves toward an IPO

4

ServiceNow continues layoffs as it restructures around AI

5

Israel's Iron Dome and Arrow makers unlikely to reach the IPO market before 2027 as Tomer joins the queue

Quarterly Reports

7 stories about Quarterly Reports

בצלאל מכליס נשיא אלביט מערכות

Elbit Systems records $60 million in write-offs due to Covid-19

26.10.20|James Spiro

The company had a tough quarter due to the reduced demand for aviation products, but still saw profits jump

ועידת התעשייה של ישראל גיל שויד מייסד מנכ"ל צ'ק פוינט

Check Point CEO says government should not aid the cyber industry

22.10.20|Sophie Shulman

The Nasdaq listed cybercompany reported $509 million in revenues in the third quarter of 2020

מנכ"ל טבע קאר שולץ קור שולץ קר שולץ מנכ"ל טבע פברואר 2018

Teva Quarterly Report Meets Analyst Expectations

07.11.19|Sophie Shulman

The Israeli drugmaker’s revenues dropped 6% in the third quarter of 2019 to $4.26 billion. Debt dropped by $1.8 billion to $26.9 billion

ברק עילם מנכל נייס

Nice's Quarterly Results Bolstered by Its Growing Cloud Business

The software company published its second-quarter reports for 2018 on Thursday, reporting a 10% year-over-year increase in revenues

אורי מוקדי סייברארק

CyberArk Announces 35% Year-Over-Year Revenue Increase for Second Quarter

08.08.18|Lilach Baumer

The information security company upped its guidance for 2018 after exceeding quarterly guidance on all metrics

There May Be a Silver Lining to Teva’s Woes

06.11.17|Eli Shimony

Analysts have lowered their target price for Teva following the company's less than stellar third quarter reports, but the company can still turn its luck around with new drugs and a willingness to tighten the belt

מנכ"ל טבע החדש קור שולץ 2

Generic Dependence Threatens Teva’s Ability to Haul Debt Load

05.11.17|Dror Reich and Lilach Baumer

Teva’s stock price dropped 18.7% last week after the company lowered its annual forecasts. On Friday, S&P changed the company’s outlook to negative